At FCE Pharma 2011 (May 24 to 26) at the Transamerica Expo Center (Aisle K/L – Stand 260, Gerresheimer now intends to present its entire portfolio of plastic pharmaceutical packaging products in its first collective product catalogue specifically for the Latin and South American market.
"Gerresheimer’s acquisition of Védat this year demonstrates just how significant the Latin and South American pharma market is for the group. We have seven production plants for customers in this market where we effectively combine local production operations with our global expertise,” explained Jens Friis, Gerresheimer’s Vice President Plastic Packaging South America.
The South American Gerresheimer companies will be demonstrating this new strength to an international public as joint exhibitors at this year’s FCE Pharma.
Another premiere is the first plastic pharmaceutical packaging product catalog, which is being published jointly by Gerresheimer Plãsticos São Paulo, Gerresheimer Védat and Gerresheimer Buenos Aires in Portuguese and Spanish. The 30-page catalog presents their comprehensive range of pharmaceutical packaging products and systems. It features dropper bottles for eye drops, spray bottles for nasal sprays, PET bottles for cough medicine, PE containers for tablets, plus a wide range of caps, closures and all kinds of accessories such as dosing caps, droppers, measuring cups, dosing syringes and the product group of applicators. The new product catalogue can also be downloaded from the internet.
Gerresheimer will also be showcasing a comprehensive range of Mexican-made transparent and brown borosilicate glass at FCE Pharma. It extends from glass category III to neutral glass of type I and from vials, ampoules and cartridges to ready-to-fill disposable syringes.
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of around one billion euros and has around 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.